المؤلفون: Nikolic-Paterson D.J., Mulley W.R.

مصطلحات الفهرس: regulatory T lymphocyte, review, abatacept/pd [Pharmacology], belatacept/pd [Pharmacology], indoleamine 2,3 dioxygenase, tryptophan, priority journal, antioxidant activity, apoptosis, catabolism, dendritic cell, drug binding, drug mechanism, enzyme activity, human, immunocompetent cell, immunosuppressive treatment, kidney transplantation, nonhuman, protein expression, protein function, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31595
Click here for full text options
LibKey Link

المؤلفون: Hoi A.Y., Littlejohn G.O.

مصطلحات الفهرس: nonhuman, pathogenesis, review, rheumatoid arthritis/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], T lymphocyte activation, treatment outcome, treatment response, abatacept/ae [Adverse Drug Reaction], abatacept/ct [Clinical Trial], abatacept/cb [Drug Combination], abatacept/do [Drug Dose], abatacept/dt [Drug Therapy], abatacept/pd [Pharmacology], abatacept/sc [Subcutaneous Drug Administration], azathioprine/cb [Drug Combination], azathioprine/dt [Drug Therapy], CD28 antigen/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], HLA B7 antigen/ec [Endogenous Compound], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], mycophenolic acid 2 morpholinoethyl ester/cb [Drug Combination], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], immune response, antigen presenting cell, B lymphocyte, disease severity, drug efficacy, drug indication, drug safety, drug treatment failure, human, immunosuppressive treatment, infection/si [Side Effect], loading drug dose, lupus erythematosus nephritis/co [Complication], lupus erythematosus nephritis/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28344
Click here for full text options
LibKey Link

المؤلفون: Nikolic-Paterson D.J., Mulley W.R.

مصطلحات الفهرس: regulatory T lymphocyte, review, abatacept/pd [Pharmacology], belatacept/pd [Pharmacology], indoleamine 2,3 dioxygenase, tryptophan, priority journal, antioxidant activity, apoptosis, catabolism, dendritic cell, drug binding, drug mechanism, enzyme activity, human, immunocompetent cell, immunosuppressive treatment, kidney transplantation, nonhuman, protein expression, protein function, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31595
LibKey Link

المؤلفون: Hoi A.Y., Littlejohn G.O.

مصطلحات الفهرس: nonhuman, pathogenesis, review, rheumatoid arthritis/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], T lymphocyte activation, treatment outcome, treatment response, abatacept/ae [Adverse Drug Reaction], abatacept/ct [Clinical Trial], abatacept/cb [Drug Combination], abatacept/do [Drug Dose], abatacept/dt [Drug Therapy], abatacept/pd [Pharmacology], abatacept/sc [Subcutaneous Drug Administration], azathioprine/cb [Drug Combination], azathioprine/dt [Drug Therapy], CD28 antigen/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], HLA B7 antigen/ec [Endogenous Compound], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], mycophenolic acid 2 morpholinoethyl ester/cb [Drug Combination], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], immune response, antigen presenting cell, B lymphocyte, disease severity, drug efficacy, drug indication, drug safety, drug treatment failure, human, immunosuppressive treatment, infection/si [Side Effect], loading drug dose, lupus erythematosus nephritis/co [Complication], lupus erythematosus nephritis/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28344
LibKey Link